Literature DB >> 21873707

Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope.

Stefan H Hohnloser, Stuart J Connolly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21873707     DOI： 10.1093/eurheartj/ehr344

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  4 in total

1.  Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease.

Authors:  Rami Riziq-Yousef Abumuaileq; Emad Abu-Assi; Andrea López-López; Sergio Raposeiras-Roubin; Moisés Rodríguez-Mañero; Luis Martínez-Sande; Francisco Javier García-Seara; Xesus Alberte Fernandez-López; Jose Ramón González-Juanatey
Journal:  World J Cardiol       Date:  2015-10-26

Review 2.  Care transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safety.

Authors:  Steven Deitelzweig
Journal:  Ochsner J       Date:  2013

3.  [Role of the new oral anticoagulants in comparison to vitamin K antagonists in practice].

Authors:  A Osterspey; A Krome
Journal:  Herz       Date:  2012-06       Impact factor: 1.443

4.  The impact of renal function on efficacy and safety of new oral anticoagulant in atrial fibrillation patients: A systemic review and meta-analysis.

Authors:  Yi-Yue Gui; Song Zou; Wen-Long Yang; Shen-Zhen Gong; Zhi-Fu Cen; Zhong-Hui Xie; Kai-Jun Cui
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.